Literature DB >> 20512444

Effect of 450-mg loading dose of clopidogrel on platelet function in Japanese patients undergoing coronary stent placement.

Kenichi Fukushima1, Yoshio Kobayashi, Hideki Kitahara, Yo Iwata, Nakabumi Kuroda, Masayuki Ooyama, Fumio Nomura, Issei Komuro.   

Abstract

Usefulness of higher (>300 mg) loading doses of clopidogrel has been demonstrated in studies from the United States and Europe. The present study evaluated platelet aggregation after the administration of a 450-mg loading dose of clopidogrel in Japanese patients undergoing coronary stenting. Platelet aggregation was serially measured at baseline, and 2, 4, 6, and 8 h after 450-mg clopidogrel loading in 25 patients undergoing coronary stenting. Platelets were stimulated with 5 and 20 micromol/l adenosine diphosphate (ADP) and aggregation was assessed by optical aggregometry. Platelet aggregation (5 micromol/l ADP 42.8% +/- 13.5% and 20 micromol/l ADP 51.2% +/- 11.6%) was significantly suppressed <or=4 h after 450-mg clopidogrel loading. There were no adverse events except one minor nasal bleed. The present study shows that platelet inhibition is achieved <or=4 h after the administration of a 450-mg clopidogrel loading dose in Japanese patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20512444     DOI: 10.1007/s00380-009-1190-x

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  23 in total

1.  Pharmacokinetics of clopidogrel after administration of a high loading dose.

Authors:  Dirk Taubert; Adnan Kastrati; Steffi Harlfinger; Olga Gorchakova; Andreas Lazar; Nicolas von Beckerath; Albert Schömig; Edgar Schömig
Journal:  Thromb Haemost       Date:  2004-08       Impact factor: 5.249

Review 2.  Antiplatelet drug nonresponsiveness.

Authors:  Patrick Gladding; Mark Webster; John Ormiston; Sarah Olsen; Harvey White
Journal:  Am Heart J       Date:  2008-04       Impact factor: 4.749

3.  Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement.

Authors:  M Gawaz; M Seyfarth; I Müller; S Rüdiger; G Pogatsa-Murray; B Wolf; A Schömig
Journal:  Am J Cardiol       Date:  2001-02-01       Impact factor: 2.778

4.  The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting.

Authors:  Paul A Gurbel; Kevin P Bliden; Kevin M Hayes; Jason A Yoho; William R Herzog; Udaya S Tantry
Journal:  J Am Coll Cardiol       Date:  2005-05-03       Impact factor: 24.094

5.  Incidence of side-effects of ticlopidine after sirolimus-eluting stent implantation.

Authors:  Kenichi Fukushima; Yoshio Kobayashi; Tomonobu Okuno; Yoshitake Nakamura; Masayoshi Sakakibara; Takashi Nakayama; Nakabumi Kuroda; Akira Miyazaki; Youichi Shimizu; Issei Komuro
Journal:  Circ J       Date:  2007-04       Impact factor: 2.993

6.  Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations.

Authors:  S P Myrand; K Sekiguchi; M Z Man; X Lin; R-Y Tzeng; C-H Teng; B Hee; M Garrett; H Kikkawa; C-Y Lin; S M Eddy; J Dostalik; J Mount; J Azuma; Y Fujio; I-J Jang; S-G Shin; M R Bleavins; J A Williams; J D Paulauskis; K D Wilner
Journal:  Clin Pharmacol Ther       Date:  2008-03-19       Impact factor: 6.875

7.  Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation.

Authors:  I Moussa; M Oetgen; G Roubin; A Colombo; X Wang; S Iyer; R Maida; M Collins; E Kreps; J W Moses
Journal:  Circulation       Date:  1999-05-11       Impact factor: 29.690

8.  Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction.

Authors:  Wei C Lau; Lucy A Waskell; Paul B Watkins; Charlene J Neer; Kevin Horowitz; Amy S Hopp; Alan R Tait; David G M Carville; Kirk E Guyer; Eric R Bates
Journal:  Circulation       Date:  2003-01-07       Impact factor: 29.690

9.  Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.

Authors:  Jacqueline Saw; Steven R Steinhubl; Peter B Berger; Dean J Kereiakes; Victor L Serebruany; Danielle Brennan; Eric J Topol
Journal:  Circulation       Date:  2003-08-18       Impact factor: 29.690

10.  Effect of 150-mg vs 300-mg loading doses of clopidogrel on platelet function in Japanese patients undergoing coronary stent placement.

Authors:  Kenichi Fukushima; Yoshio Kobayashi; Hideki Kitahara; Yo Iwata; Takashi Nakayama; Nakabumi Kuroda; Masayuki Ooyama; Fumio Nomura; Issei Komuro
Journal:  Circ J       Date:  2008-08       Impact factor: 2.993

View more
  2 in total

1.  Effect of chronic kidney disease on platelet reactivity to dual-antiplatelet therapy in patients treated with drug-eluting stents.

Authors:  Takahide Arai; Akio Kawamura; Yumiko Matsubara; Kenji Yokoyama; Yasuo Ikeda; Keiichi Fukuda; Mitsuru Murata
Journal:  Heart Vessels       Date:  2011-08-12       Impact factor: 2.037

2.  Complete versus incomplete revascularization for treatment of multivessel coronary artery disease in the drug-eluting stent era.

Authors:  Young Bin Song; Sang-Yeub Lee; Joo-Yong Hahn; Seung-Hyuk Choi; Jin-Ho Choi; Sang Hoon Lee; Kyung Pyo Hong; Jeong Euy Park; Hyeon-Cheol Gwon
Journal:  Heart Vessels       Date:  2011-07-16       Impact factor: 2.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.